Table 2 Immunohistochemical results of MMPs and TIMPs in each subtype
Characteristics | Tumor subtype | Pvalue* | ||
|---|---|---|---|---|
Luminal A (n = 123) | Basal-like (n = 31) | HER2 (n = 17) | ||
Posistive No/Cases (%) | Positive No/Cases (%) | Positive No/Cases (%) | ||
MMP 1 | Â | Â | Â | Â |
 Tumoral | 13/123 (10.6) | 3/31 (9.7) | 2/17 (11.8) | 1.000 |
 Stromal | 96/123 (78.0) | 22/31 (71.0) | 13/17 (76.5) | 0.470 |
MMP 2 | Â | Â | Â | Â |
 Tumoral | 47/123 (38.2) | 11/31 (35.5) | 7/17 (41.2) | 0.935 |
 Stromal | 4/123 (3.3) | 2/31 (6.5) | 0/17 (0) | 0.641 |
MMP 7 | Â | Â | Â | Â |
 Tumoral | 100/123 (81.3) | 31/31 (100) | 12/17 (70.6) | 0.005 |
 Stromal | 35/123 (28.5) | 11/31 (35.5) | 5/17 (29.4) | 0.767 |
MMP 9 | Â | Â | Â | Â |
 Tumoral | 28/123 (22.7) | 11/31 (35.5) | 12/17 (70.6) | 0.000 |
 Stromal | 6/123 (4.9) | 0/31 (0) | 0/17 (0) | 0.507 |
MMP 11 | Â | Â | Â | Â |
 Tumoral | 115/123 (93.5) | 30/31 (96.8) | 17/17 (100) | 1.000 |
 Stromal | 101/123 (82.1) | 29/31 (93.5) | 13/17 (76.5) | 0.253 |
MMP 13 | Â | Â | Â | Â |
 Tumoral | 45/123 (36.6) | 17/31 (54.8) | 12/17 (70.6) | 0.016 |
 Stromal | 9/123 (7.32) | 5/31 (16.1) | 5/17 (29.4) | 0.016 |
MMP 14 | Â | Â | Â | Â |
 Tumoral | 67/123 (54.5) | 21/31 (67.7) | 12/17 (70.6) | 0.331 |
 Stromal | 42/123 (34.1) | 5/31 (16.1) | 5/17 (29.4) | 0.118 |
TIMP 1 | Â | Â | Â | Â |
 Tumoral | 64/122 (52.5) | 12/31 (38.7) | 10/17 (58.8) | 0.274 |
 Stromal | 22/122 (18.0) | 4/31 (12.9) | 2/17 (11.8) | 0.748 |
TIMP 2 | Â | Â | Â | Â |
 Tumoral | 62/123 (50.4) | 16/31 (51.6) | 11/17 (64.7) | 0.657 |
 Stromal | 16/123 (13.0) | 6/31 (19.4) | 4/17 (23.5) | 0.368 |
TIMP 3 | Â | Â | Â | Â |
 Tumoral | 100/123 (81.3) | 27/31 (87.1) | 16/17 (94.1) | 0.605 |
 Stromal | 45/123 (36.6) | 18/31 (58.1) | 8/17 (47.1) | 0.107 |